Complexo Hospitalario Universitario de Ferrol
Centro de atención
![Foto de Complexo Hospitalario Universitario de Ferrol](/img/noimage.png)
![Foto de Hospital San Pedro de Alcántara](/img/noimage_org.png)
Hospital San Pedro de Alcántara
Cáceres, EspañaPublicacións en colaboración con investigadores/as de Hospital San Pedro de Alcántara (19)
2022
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019
Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry
PLoS ONE, Vol. 16, Núm. 2 February
-
Real-life use of ramucirumab in gastric cancer in Spain: The RAMIS study
Future Oncology, Vol. 17, Núm. 14, pp. 1777-1791
2020
-
Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018
Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407
-
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834
2019
-
IHDIP: A controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients
BMC Nephrology, Vol. 20, Núm. 1
-
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients
Annals of Hematology, Vol. 98, Núm. 2, pp. 321-330
-
Spanish home enteral nutrition registry of the year 2016 and 2017 from the NADYA-SENPE Group
Nutricion Hospitalaria, Vol. 36, Núm. 1, pp. 233-237
2018
-
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467
-
Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017
Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496
-
Rationale and design of DiPPI: A randomized controlled trial to evaluate the safety and effectiveness of progressive hemodialysis in incident patients
Nefrologia, Vol. 38, Núm. 6, pp. 630-638
2017
-
Registro del Grupo NADYA-SENPE de nutrición enteral domiciliaria en España, años 2014 y 2015
Nutricion Hospitalaria, Vol. 34, Núm. 1, pp. 15-18
2016
-
Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up
Journal of the American College of Cardiology, Vol. 67, Núm. 11, pp. 1278-1285
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433
2010
-
Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain
Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277